Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).

Capell WH, Bonaca MP, Nehler MR, Chen E, Kittelson JM, Anand SS, Berkowitz SD, Debus ES, Fanelli F, Haskell L, Patel MR, Bauersachs R, Hiatt WR.

Am Heart J. 2018 May;199:83-91. doi: 10.1016/j.ahj.2018.01.011. Epub 2018 Feb 3.

PMID:
29754671
2.

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.

Hess CN, Norgren L, Ansel GM, Capell WH, Fletcher JP, Fowkes FGR, Gotts├Ąter A, Hitos K, Jaff MR, Nordanstig J, Hiatt WR.

Circulation. 2017 Jun 20;135(25):2534-2555. doi: 10.1161/CIRCULATIONAHA.117.024469. Review. Erratum in: Circulation. 2017 Nov 7;136(19):e347.

PMID:
28630267
3.

A randomized trial of heart failure disease management in skilled nursing facilities (SNF Connect): Lessons learned.

Daddato A, Wald HL, Horney C, Fairclough DL, Leister EC, Coors M, Capell WH, Boxer RS.

Clin Trials. 2017 Jun;14(3):308-313. doi: 10.1177/1740774517690529. Epub 2017 Jan 31.

PMID:
28135830
4.

Ethical conduct of palliative care research: enhancing communication between investigators and institutional review boards.

Abernethy AP, Capell WH, Aziz NM, Ritchie C, Prince-Paul M, Bennett RE, Kutner JS.

J Pain Symptom Manage. 2014 Dec;48(6):1211-21. doi: 10.1016/j.jpainsymman.2014.05.005. Epub 2014 May 28.

5.

Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.

Capell WH, Schlaepfer IR, Wolfe P, Watson PA, Bessesen DH, Pagliassotti MJ, Eckel RH.

Am J Physiol Endocrinol Metab. 2010 Oct;299(4):E576-83. doi: 10.1152/ajpendo.00618.2009. Epub 2010 Jul 13.

6.

Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet.

Hernandez TL, Sutherland JP, Wolfe P, Allian-Sauer M, Capell WH, Talley ND, Wyatt HR, Foster GD, Hill JO, Eckel RH.

Am J Clin Nutr. 2010 Mar;91(3):578-85. doi: 10.3945/ajcn.2009.27909. Epub 2010 Jan 27.

7.

Plant sterols added to combination statin and colesevelam hydrochloride therapy failed to lower low-density lipoprotein cholesterol concentrations.

Linnebur SA, Capell WH, Saseen JJ, Wolfe P, Eckel RH.

J Clin Lipidol. 2007 Dec;1(6):626-33. doi: 10.1016/j.jacl.2007.10.004. Epub 2007 Oct 18.

PMID:
21291705
8.

Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus.

Hernandez TL, Capell WH, Wolfe P, Gerard LA, Eckel RH.

Am J Cardiol. 2006 Dec 15;98(12):1656-9. Epub 2006 Oct 25.

PMID:
17145229
9.

Severe hypertriglyceridemia with a history of treatment failure.

Capell WH, Eckel RH.

Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):53-8; quiz 59.

PMID:
16929366
10.

Treatment of hypertriglyceridemia.

Capell WH, Eckel RH.

Curr Diab Rep. 2006 Jun;6(3):230-40. Review.

PMID:
16898578
11.

Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance.

Schlaepfer IR, Pulawa LK, Ferreira LD, James DE, Capell WH, Eckel RH.

J Lipid Res. 2003 Jun;44(6):1174-81. Epub 2003 Apr 16.

12.

Short-term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia.

Capell WH, DeSouza CA, Poirier P, Bell ML, Stauffer BL, Weil KM, Hernandez TL, Eckel RH.

Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):307-13.

PMID:
12588776

Supplemental Content

Loading ...
Support Center